How Allison Love is Transforming Fertility Treatments
Infertility is a deeply personal and global challenge, affecting one in six people in their lifetime. For many, Assisted Reproductive Technology (ART) like IVF provides hope. However, the process of egg and embryo freezing (cryopreservation) through vitrification is technically demanding and depends heavily on the skill of embryologists. Recognising the limitations of current methods, Allison Love, a MedTech innovator, is reimagining the future of fertility preservation with a unique solution.
From Engineering Excellence to Life-Changing Innovation
Allison Love began her career as a mechanical engineer, with over 20 years of experience in medical device product development. Having worked extensively in the ART industry as the Director of Product Development at Genea Biomedx and Chief Engineer at Fertilis, Allison brings a wealth of expertise in delivering innovative solutions to regulated global markets.
But Allison’s motivation is deeply personal. “Friends and family have undergone IVF, and I’ve seen their struggles to conceive.
I’ve worked alongside committed embryologists and pioneers in Australian IVF and witnessed the challenges they face with vitrification,” she shares. This personal connection, coupled with her professional insights, drives her mission to improve outcomes for patients, embryologists, and labs alike.
Revolutionising a 30-Year-Old Problem with Advanced Technology
The status quo in vitrification relies on dated technology, using basic tools like petri dishes that require embryologists to “fish around” for fragile cells—a process fraught with variability and inefficiency. While competitors are attempting to introduce automation, these solutions have seen limited market success because they fail to address key user needs.
Allison’s approach is both simple and groundbreaking: a custom-designed IVF dish, built using advanced nanoscale 3D printing technology (2PP), that eliminates manual handling and operator dependency. “By applying the latest technologies, we can deliver a product that is not only innovative but also practical and scalable,” she explains.
Allison has already proven her ability to create impactful solutions. She previously developed a custom IVF dish designed for a fertilisation technique called ICSI, which led to a remarkable 56% improvement in embryo development in animal testing. This success showcases her talent for delivering innovative results that make a real difference.
A Startup Poised to Disrupt a $42 Billion Market
Allison’s business is in its early stages, embodying the essence of a true startup. With a strong focus on building a foundation for innovation, her venture leverages advanced nanoscale 3D printing technology for rapid prototyping and iteration. Specialising in MedTech and targeting fertility preservation within Assisted Reproductive Technology (ART), Allison is rethinking a decades-old problem with a simple yet groundbreaking product. Operating in the rapidly expanding $42 billion fertility market—where the vitrification segment alone is valued at $9.5 billion and growing at 17% annually—her solution is uniquely positioned to capture a significant share of this opportunity.
From Concept to Commercialisation: A Network of Expertise
Allison’s extensive industry network is a key asset in turning her vision into reality. By collaborating with Australian IVF experts and leveraging state and national specialist suppliers like the Melbourne Centre for Nanofabrication and Planet Innovation, she plans to fully develop, test, and manufacture her product in compliance with global regulations.
Her ability to assemble a team of experts in scientific research, engineering, clinical practice, and operations ensures not only that the technical challenges will be solved but also that the product will be successfully rolled out to global markets.
The Role of Press Play in Shaping the Vision
Participating in the Press Play program was transformative for Allison. “The program provided the structure and support I needed to refine my value proposition, validate my assumptions, and rethink my approach,” she says.
Learning to conduct customer interviews and apply the “Mum Test” framework allowed Allison to uncover valuable insights into the needs of embryologists and clinics. This not only informed her product design but also expanded its scope to address broader challenges in the ART space.
Pioneering a Better Future for Fertility Treatments
Allison’s innovation represents more than just a technical breakthrough—it’s a step toward greater accessibility and reliability in fertility preservation. “For many families, a frozen embryo might be their last chance. I want to make that chance count,” she says.
Her journey continues with the Elevate You Programme, where she is honing her confidence and preparing to secure seed investment. With a clear vision, a proven track record, and the right support, Allison is well on her way to bringing her product to market and transforming lives globally.
If you would like to be a founder, apply or express your interest to be a part of our program.